David A. Siegel Chroma Dex Corp. Transaction History

Two Sigma Advisers, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.48 - $2.19 $28,268 - $41,829	-19,100 Reduced 38.82%	30,100 $46,000
Q4 2022 Feb 14, 2023	BUY	$1.25 - $1.94 $9,000 - $13,968	7,200 Added 17.14%	49,200 $82,000
Q3 2022 Nov 14, 2022	SELL	$1.19 - $2.06 $12,257 - $21,218	-10,300 Reduced 19.69%	42,000 $52,000
Q2 2022 Aug 15, 2022	BUY	$1.59 - $2.7 $318 - $540	200 Added 0.38%	52,300 $87,000
Q1 2022 May 16, 2022	SELL	$2.02 - $3.92 $26,058 - $50,568	-12,900 Reduced 19.85%	52,100 $128,000
Q4 2021 Feb 14, 2022	BUY	$3.74 - $6.7 $243,100 - $435,500	65,000 New	65,000 $243,000
Q1 2021 May 17, 2021	SELL	$4.59 - $18.74 $100,062 - $408,531	-21,800 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.93 - $5.5 $16,899 - $23,650	-4,300 Reduced 16.48%	21,800 $105,000
Q3 2020 Nov 16, 2020	BUY	$4.01 - $5.56 $21,253 - $29,467	5,300 Added 25.48%	26,100 $105,000
Q2 2020 Aug 14, 2020	BUY	$3.0 - $5.52 $62,400 - $114,815	20,800 New	20,800 $95,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $362M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.